PTPN1 and congenital bilateral aplasia of vas deferens from CFTR mutation: Finally, PTP1B overexpression was also identified as a therapeutic target for the treatment of potentially life-threatening stenosis of the aortic valve induced by calcific aortic valve disease (CAVD) [171].